TORONTO, Nov. 28, 2022 /CNW/ - Apobiologix, a division of Apotex Inc., expanded its product portfolio with the launch of a pre-filled autoinjector for Lapelga®, the company's biosimilar pegfilgrastim ...
The auto injector market represents a rapidly expanding segment within the global pharmaceutical delivery systems industry, driven by the increasing prevalence of chronic diseases and the growing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results